Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma

NCT05740748 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Asthma, Allergic

Interventions

DRUG: Tezepelumab
DRUG: Placebo

Sponsor

McMaster University

Collaborators

[object Object]